Tevogen Bio Holdings Inc. (NASDAQ:TVGN) price on Friday, October 25, rose 19.14% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $3.05.
A look at the stock’s price movement, the close in the last trading session was $2.56, moving within a range at $2.4 and $3.09. The beta value (5-Year monthly) was 0.312. Turning to its 52-week performance, $21.09 and $0.26 were the 52-week high and 52-week low respectively. Overall, TVGN moved 644.08% over the past month.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Tevogen Bio Holdings Inc.’s market cap currently stands at around $520.48 million, with investors looking forward to this quarter’s earnings report slated for in November.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TVGN is a 50% Buy. On the other hand, the stock is on average a 25% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
TVGN’s current price about 186.97% and 323.57% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 84.47, while 7-day volatility ratio is 33.68% and 32.49% in the 30-day chart. Further, Tevogen Bio Holdings Inc. (TVGN) has a beta value of 0.26, and an average true range (ATR) of 0.44.
If we refocus on Tevogen Bio Holdings Inc. (NASDAQ:TVGN), historical trading data shows that trading volumes averaged 87.26 over the past 10 days and 13.97 million over the past 3 months. The company’s latest data on shares outstanding shows there are 170.65 million shares.
The 87.13% of Tevogen Bio Holdings Inc.’s shares are in the hands of company insiders while institutional holders own 3.82% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.58 million on 2024-09-30, giving us a short ratio of 3.27. The data shows that as of 2024-09-30 short interest in Tevogen Bio Holdings Inc. (TVGN) stood at 183.0 of shares outstanding, with shares short falling to 0.59 million registered in 2024-08-30. Current price change has pushed the stock -72.60% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TVGN stock continues to rise going into the next quarter.
